2017 Meeting

Fourth Annual Meeting:
Monday, October 23, 2017
The George Washington University Science and Engineering Hall
Washington, DC

Register for the conference (and pay dues) here:
Meeting Registration

2017_meeting_agenda-page-001 (1)

Invited speakers:

Edward Lakatta
National Institutes of Health

LakattaAs the senior investigator in the Laboratory of Cardiovascular Science at the NIA, Dr. Lakatta has the overall goals (1) to identify age-associated changes that occur within the cardiovascular system and to determine the mechanisms for these changes; (2) to study myocardial structure and function and to determine how age interacts with chronic disease states to alter function; (3) to study basic mechanisms in excitation-contraction coupling and how these are modulated by surface receptor signaling pathways in cardiac muscle; (4) to determine the chemical nature and sequence of intermediate reactions controlling the movement of ions through ionic channels and pumps present in myocardium, and how these are affected by aging and disease; (5) to determine mechanisms that govern neuro-hormonal behavioral aspects of hypertension; (6) to determine mechanisms of normal and abnormal function of vascular smooth muscle and endothelial cells; and (7) to establish the potentials and limitations of new therapeutic approaches such as gene transfer techniques. In meeting these objectives, studies are performed in human volunteers, intact animals, isolated heart and vascular tissues, isolated cardiac and vascular cells, and subcellular organelles.

Steven Malin
University of Virginia

Dr. Steven K. Malin is an Assistant Professor in the Department of Kinesiology within theMalin_Steve_220x220 Curry School of Education and holds joint appointments in the Division of Endocrinology & Metabolism within the School of Medicine and the Robert M. Berne Cardiovascular Research Center. Dr. Malin has expertise in exercise metabolism and human nutrition. The primary focus of his clinical translational research is to prevent/treat obesity related type 2 diabetes. To accomplish this, Dr. Malin views exercise as a “drug” that when prescribed in an appropriate way (i.e. intensity/duration/frequency/mode) can optimize the prevention/treatment of cardiometabolic disease risk in individuals across the lifespan. His research focuses on the interaction of exercise with nutrient intake, pharmacology, and/or bariatric surgery to maximize improvements in insulin resistance, substrate oxidation, inflammation, and vascular function. Dr. Malin is the Director of the Applied Metabolism & Physiology (AMP) Laboratory and Co-Director of the Exercise Physiology Graduate Program in the Department of Kinesiology. He currently teaches undergraduate and graduate courses in Exercise Physiology and Energy Metabolism, and is an active member of the American College of Sports Medicine, American Diabetes Association, Obesity Society, and the American Physiological Society.

Jen Pluznick
Johns Hopkins University

jen headshotOlfactory Receptors, Gut Microbiota, and the Kidney

Jen Pluznick received her Ph.D. in Renal Physiology from the University of Nebraska Medical Center (Omaha, NE) in 2005. She then spent five years as a postdoctoral fellow at Yale University (New Haven, CT), where she studied both renal physiology and sensory biology systems (in particular, olfaction). Jen’s research interests are focused on how the renal and cardiovascular systems employ G-protein coupled receptor “sensory” signaling pathways in order to monitor various substances in the plasma and forming urine, and thus aid in the maintenance of homeostasis.

Kevin Cleary
Children’s National Health System

Robotically Assisted Rehabilitation for Pediatrics

cleary headshotKevin Cleary received BS and MS degrees from Duke University, followed by a PhD from the University of Texas, all in Mechaniical Engineering. He was an NSF sponsored postdoctoral fellow in Japan and worked for the Department of Defense and NASA before starting his academic career.  At Georgetown University, he developed robotics and image-guided systems for Interventional Radiology. He joined Children’s in 2010 to help start the Sheikh Zayed Institute for Pediatric Surgical Innovation and serves as the Technical Director for the Bioengineering Initiative.

Stephanie Devaney
National Institutes of Health

Devaney 2016

Stephanie Devaney is the Deputy Director of the All of Us Research Program at the National Institutes of Health. Prior to this she led the coordination of the Precision Medicine Initiative from the Office of the Chief of Staff at the White House. In this role she coordinated the many components of the Initiative and guided the vision of the overall effort, along with the many federal partners. Before joining the White House, Stephanie worked in the Office of the Director at the National Institutes of Health. There she helped advance policies critical to biomedical research and the NIH mission and assisted in the development of programs and research initiatives to advance national scientific priorities, including the Precision Medicine Initiative. Prior to that, Stephanie was a researcher at the Genetics and Public Policy Center at Johns Hopkins University. There she conducted research on pharmacogenetics and drug labeling; performed a meta-analysis of non-invasive fetal gender genetic testing; and was involved in public engagement surrounding the many ethical and social issues that are emerging with novel genomic technologies. Stephanie received her Ph.D. in Molecular Genetics from the George Washington University and her B.S. in Biology from The Ohio State University.

Richard Lovering
University of Maryland Baltimore

Assessment of damage in skeletal muscle injury and diseaseLovering_Richard.jpg

Dr. Lovering is an Associate Professor in the Department of Orthopaedics at the University of Maryland Baltimore – School of Medicine (UMB-SOM), with secondary appointments in the Departments of Physiology, Anatomy & Neurobiology, and Physical Therapy & Rehabilitation Science. Dr. Lovering has been a licensed clinician (board certified specialist in orthopedic physical therapy) for 29 years and has extensive training in the basic sciences. He completed his PhD in 2003 under the mentorship of Dr. Patrick De Deyne and a post-doctoral fellowship under the mentorship of Dr. Robert Bloch in the Department of Physiology at UMB-SOM. His laboratory has been continuously funded by NIH and focuses on muscle injury and disease by comparing histopathology, in vivo imaging, and in vivo muscle function.

An Massaro
Children’s National Health System


Dr. An Massaro is an attending neonatologist in the Division of Neonatology at Children’s National Health System. She is also Pediatric Residency Assistant Program Director, Director of Residency Research. Dr. Massaro’s research is focused on improving the treatment of babies with perinatal hypoxic ischemic encephalopathy (HIE), a major cause of brain injury in newborns. Dr. Massaro has focused on a physiological biomarker, heart rate variability (HRV), which can help better predict neurological outcomes, including whether different cooling patterns can improve care. She is also involved in a multi-center clinical trial to determine whether erythropoietin, a hormone naturally secreted by the kidneys and commonly used to treat anemia, helps to prevent brain injury in these infants.

Laura Olivieri
Children’s National Health System


“3D Printing and Congenital Heart Disease: A heart model speaks 10,000 words”

Laura Jean Olivieri, MD is a board-certified Pediatric Cardiologist specializing in Advanced Cardiac Imaging at Children’s National Health System in Washington, D.C. and Assistant Professor of Pediatrics at George Washington School of Medicine.  She graduated from University of Chicago Pritzker School of Medicine, and completed her pediatric residency at Brown University in Providence, RI, where she also was invited to stay for a chief year.  She completed her training in pediatric cardiology at Children’s National Medical Center in Washington, DC following by a year in advanced cardiac imaging at the National Heart, Lung and Blood Institute specializing in cardiovascular magnetic resonance imaging.  She is considered a  leader  in  the  field  of  3-dimensional reconstruction of  congenital  heart  defects from 3D imaging, and serves as Director of the 3D Cardiac Printing Lab at Children’s National Sheikh Zayed Institute for Surgical Innovation.  She is most interested in improving image acquisition using MRI and echocardiographic in 3D printing of heart models. She also serves as co-Principal Investigator for the Interventional Cardiac Magnetic Resonance contract with National Heart Lung and Blood Institute, a 7.3 million dollar, 5-year contract aimed at using CMR to guide interventional cardiac catheterization procedures, using less sedation for diagnostic CMR procedures and to advance diagnostic CMR capabilities in order to use less invasive testing in children and adults with congenital heart disease.